Use of a virulence-associated protein based enzyme-linked immunosorbent assay for Rhodococcus equi serology in horses.
An enzyme-linked immunosorbent assay (ELISA) was developed against Rhodococcus equi using Triton X-114 detergent extracted whole cell material, in which the virulence associated protein (VapA) predominated. Enzymelinked immunosorbent assay titres corresponded to antibody reacting with VapA on Western blots. There was considerable variation in antibody titres of nonimmunised mares and in the time when the colostrally derived antibody of their foals had declined to low or undetectable titres. In general, antibodies in foals declined to their lowest levels at age 4-8 weeks. Seroconversion occurred in foals age 8-10 weeks, but the precise time depended on maternal titre and the month in which the foal was born. Foals reaching age 8 weeks in late summer showed more marked seroconversion than foals born earlier. The ELISA was used to follow the response to immunisation with the same Triton X-114 extracted material. Six mares immunised before parturition with the antigen in aluminium hydroxide adjuvant developed high titres, up to > 102,400 and transferred them to their foals through colostrum. Their foals responded to immunisation with 0.5-1.0 mg antigen 3, 5, 7 and 9 weeks after birth. Antibody titres following immunisation with similar dosage reached up to > 102,400 in a separate group of foals of nonimmunised mares. Nonvaccinated control foals seroconverted at age 6-8 weeks. The VapA based ELISA is useful to follow the course of natural infection with R. equi or immunisation with VapA based antigen.
Department of Veterinary Microbiology and Immunology, University of Guelph, Ontario, Canada.
J F
JF
Prescott
A S
AS
Fernandez
V M
VM
Nicholson
M C
MC
Patterson
J A
JA
Yager
L
L
Viel
G
G
Perkins
D000193:Actinomycetales Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D000818:Animals; D000831:Animals, Newborn; D000907:Antibodies, Bacterial / Q000097:blood*; D000942:Antigens, Bacterial / Q000276:immunology; D001426:Bacterial Proteins / Q000276:immunology*; D001428:Bacterial Vaccines / Q000276:immunology; D015153:Blotting, Western; D004591:Electrophoresis, Polyacrylamide Gel; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary*; D005260:Female; D006734:Horse Diseases / Q000276:immunology* / Q000517:prevention & control; D006736:Horses; D008562:Membrane Glycoproteins / Q000276:immunology*; D018410:Pneumonia, Bacterial / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary; D016929:Rhodococcus equi / Q000276:immunology* / Q000472:pathogenicity; D014611:Vaccination / Q000662:veterinary; D014774:Virulence; D037521:Virulence Factors
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D008562:Membrane Glycoproteins; D037521:Virulence Factors